In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™for all indicationsmatching the reference product ...
Spine injections should not be given to adults with chronic back pain because they provide little or no pain relief compared ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback